Metabolic effects of non-drug therapy of post-Covid syndrome

The performed study is devoted to the analysis of the effect of mesodiencephalic (MDM) therapy and normobaric hypoxia on the carbohydrate and lipid metabolism in the complex rehabilitation of patients with post-COVID syndrome. It has been shown that the metabolic potential of MDM therapy is more pronounced than that of hypoxic training, and with the combined use of these factors, the therapeutic effect is significantly enhanced. This phenomenon is explained by the involvement of the body in the response reaction to the effects of various functional systems, while a supraaditive type of synergistic interaction of physical factors is noted. It is proved that one of the factors limiting therapeutic effect is the presence of metabolic syndrome in patients. The use of MDM therapy makes it possible to increase the sensitivity of the body to the action of insulin, while the regression of the insulin resistance index correlates with an improvement in well-being. At the same time, the formation of adaptive type reactions is recorded, which is confirmed by an increase in the activity of glucocorticoids. The combined use of physiofactors helps to reduce the manifestations of oxidative stress.